Indonesia
· Delayed Price · Currency is IDR RSCH Statistics
Total Valuation
PT Charlie Hospital Semarang Tbk has a market cap or net worth of IDR 996.40 billion. The enterprise value is 991.83 billion.
| Market Cap | 996.40B |
| Enterprise Value | 991.83B |
Important Dates
The next estimated earnings date is Tuesday, October 29, 2024.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Charlie Hospital Semarang Tbk has 2.65 billion shares outstanding. The number of shares has increased by 189.72% in one year.
| Shares Outstanding | 2.65B |
| Shares Change (YoY) | +189.72% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | n/a |
| Float | 530.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.02 |
| PB Ratio | 6.61 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 142.50, with an EV/FCF ratio of -21.56.
| EV / Earnings | 1,261.92 |
| EV / Sales | 20.95 |
| EV / EBITDA | 142.50 |
| EV / EBIT | n/a |
| EV / FCF | -21.56 |
Financial Position
The company has a current ratio of 2.28
| Current Ratio | 2.28 |
| Quick Ratio | 1.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 330.52 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 218.12M |
| Profits Per Employee | 3.62M |
| Employee Count | 212 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +205.79% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +205.79% |
| 50-Day Moving Average | 315.60 |
| 200-Day Moving Average | 215.96 |
| Relative Strength Index (RSI) | 61.04 |
| Average Volume (20 Days) | 6,849,700 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Charlie Hospital Semarang Tbk had revenue of IDR 47.33 billion and earned 785.97 million in profits. Earnings per share was 0.27.
| Revenue | 47.33B |
| Gross Profit | 14.74B |
| Operating Income | 879.61M |
| Pretax Income | 883.98M |
| Net Income | 785.97M |
| EBITDA | 6.96B |
| EBIT | 879.61M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
| Cash & Cash Equivalents | 4.57B |
| Total Debt | n/a |
| Net Cash | 4.57B |
| Net Cash Per Share | 1.72 |
| Equity (Book Value) | 150.84B |
| Book Value Per Share | 56.92 |
| Working Capital | 5.28B |
Cash Flow
In the last 12 months, operating cash flow was 6.65 billion and capital expenditures -52.65 billion, giving a free cash flow of -46.00 billion.
| Operating Cash Flow | 6.65B |
| Capital Expenditures | -52.65B |
| Free Cash Flow | -46.00B |
| FCF Per Share | -17.36 |
Margins
Gross margin is 31.13%, with operating and profit margins of 1.86% and 1.66%.
| Gross Margin | 31.13% |
| Operating Margin | 1.86% |
| Pretax Margin | 1.87% |
| Profit Margin | 1.66% |
| EBITDA Margin | 14.71% |
| EBIT Margin | 1.86% |
| FCF Margin | -97.19% |
Dividends & Yields
PT Charlie Hospital Semarang Tbk does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -189.72% |
| Shareholder Yield | -189.72% |
| Earnings Yield | 0.07% |
| FCF Yield | -4.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PT Charlie Hospital Semarang Tbk has an Altman Z-Score of 55.04.
| Altman Z-Score | 55.04 |
| Piotroski F-Score | n/a |